CASE REPORT: CML PROGRESSION TO AML-MR WITH CLONAL CHROMOSOMAL ABNORMALITIES

CASE REPORT: CML PROGRESSION TO AML-MR WITH CLONAL CHROMOSOMAL ABNORMALITIES

Introduction: The advancement of chronic myeloid leukemia (CML) treatment through tyrosine kinase inhibitors (TKIs) has brought about a revolutionary transformation in patient outcomes, clinical responses, and survival rates. Nevertheless, specific patient subsets exhibit inferior responses to thera...

Full description

Bibliographic Details
Main Authors: S Lanes, WS Goulart, M Souza, L Mattos, MA Morais, AM Oba, C Pugliesi, R Prot-Siqueira, A Marinato
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137923006193

Internet

http://www.sciencedirect.com/science/article/pii/S2531137923006193

Similar Items